Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 1.29M | 1.56M | 1.34M | 1.07M | 1.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.29M | 1.56M | 1.34M | 1.07M | 1.42M |
| Cost of Revenue | 512.80K | 497.40K | 534.60K | 550.80K | 651.20K |
| Gross Profit | 775.80K | 1.06M | 807.40K | 517.10K | 765.00K |
| SG&A Expenses | 1.14M | 1.08M | 1.18M | 1.65M | 1.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.66M | 1.58M | 1.71M | 2.20M | 2.53M |
| Operating Income | -367.00K | -17.00K | -371.10K | -1.14M | -1.12M |
| Income Before Tax | -604.90K | -237.80K | -546.20K | -1.68M | -1.48M |
| Income Tax Expenses | -- | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -604.90K | -237.80K | -546.20K | -1.68M | -1.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 23.40K | -- | -- | -- | -- |
| Net Income | -581.50K | -237.80K | -546.20K | -1.68M | -1.48M |
| EBIT | -367.00K | -17.00K | -371.10K | -1.14M | -1.12M |
| EBITDA | -313.40K | 34.90K | -313.50K | -1.07M | -1.02M |
| EPS Basic | -0.02 | -0.01 | -0.02 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 |
| EPS Diluted | -0.02 | -0.01 | -0.02 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 27.69M | 27.46M | 26.95M | 26.77M | 26.67M |
| Average Diluted Shares Outstanding | 27.69M | 27.46M | 26.95M | 26.77M | 26.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
